Skip to content

The cross-sectional validity of three measurement instruments for central sensitization

The cross-sectional validity of three measurement instruments for central sensitization

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26154
Enrollment
100
Registered
2015-04-02
Start date
2015-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Centrale sensitization in patients with fibromyalgia

Interventions

In one session the patient will complete the Dutch Central Sensitization Inventory and two tests, a heterotopic noxious conditioning stimulation test and a submaximal exercise test. Before the tests p
on the proximal third of the calf, at the upper trapezius muscle (pars descendens) midway between the seventh cervical vertebra and the tip of the acromion, and on the middle dorsal side of the third

Sponsors

Medical Centre Alkmaar, rehabilitation department
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group 1 (n=50): Persons with fibromyalgia (diagnostic criteria 1990) Group 2 (n=50): Persons without complaints (no pain); the absence of disabling pain the past 2 weeks, no use of medication

Exclusion criteria

Exclusion criteria: - neuropathic pain - severe diseases like cancer - pregnant - cardiovascular diseases - neurological diseases - diabetes.

Design outcomes

Primary

MeasureTime frame
Outcomes of the CSI and pain pressure thresholds [PPT]

Contacts

Public ContactAdri Apeldoorn

Noordwest Ziekenhuisgroep

a.t.apeldoorn@nwz.nl+31 (0)72 5483286

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)